Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P & C Labs (Pellets & CR Products), Egypt) Versus Abilify 10 mg Orodispersible Tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands)
Condition: Healthy Interventions: Drug: Apipe (Aripiprazole10 mg); Drug: Abilify (Aripiprazole10 mg) Sponsors: Genuine Research Center, Egypt; P&C Labs, Egypt Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 7, 2023 Category: Research Source Type: clinical trials
Add-on Aripiprazole on Cardiometabolic Profile in Treatment Resistant Schizophrenia: RCT
Condition: Difference in the Change in Cardiovascular Risk in Treatment Resistant Schizophrenia Intervention: Drug: Aripiprazole 10 MG Sponsor: All India Institute of Medical Sciences, Bhubaneswar Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2023 Category: Research Source Type: clinical trials
